BioGlue: Overview

Modified on 2009/10/14 21:46 by admin
BioGlue, approved by the Food and Drug Administration in 1999 to facilitate surgical repair of acute thoracic aortic dissection, may cause serious nerve injury and paralysis of the diaphragm according to a new study conducted by the Baylor College of Medicine and presented to the Association for Academic Surgery.

The study tested BioGlue on 18 pigs. Phrenic nerve damage was reported as well as coagulation necrosis, or cell death. BioGlue, used for suture line sealing, bypass sealing and abdominal aortic sealing, was approved as an adjunct to the use of sutures and staples in vascular and cardiac repair to achieve hemostasis.

See your doctor if you suspect that BioGlue may have caused serious health problems. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Medical Devices & Implants
  2. Head, Spinal Cord, Brain & Nerve Disorders: Overview
  Name Size